Taiwan-made enterovirus vaccine clears trial, could hit market soon

Taiwan-based Medigen Vaccine Biologics Corp. (MVC) on Sunday announced positive trial results for its enterovirus 71 (EV71) virus vaccine and expressed hope the vaccine could hit the market in Taiwan next year.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)